Bruce Downey is the former chairman and CEO of Barr Pharmaceuticals (bought by Teva Pharmaceuticals) and in 2009 became a partner at New Spring Capital, a venture capital firm.[1] (wikipedia)
While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.
Together, in very short order, we'll have the broadest line of oral contraceptives of any company brand or generic,
This decision could have been reached much earlier, and we could have been well into the proceeding that they're now just starting.
We want to establish ourselves as the leading company in women's health care.
We're ready to ship in the morning, ... It should be on the shelves at some pharmacies on Friday or Saturday and available virtually nationwide by the first of next week.
We review these patents for validity and of course there's a lot of incentives on the other side to press the patent to the bursting point,
we will ... continue to press for approval of Plan B as an over-the-counter/ prescription product.
We are disappointed that the FDA did not approve our application. While we believe that a delay is not justified, we will use the opportunity presented by the FDA proceedings to continue to press for approval of Plan B as an OTC/Rx Product.
We are disappointed that the FDA did not approve our application,
